The Recall Desk
SevereFDA (Drugs)·D-0834-2026·Announced 2026-09-09

Teva Recalls Trazodone Hydrochloride Tablets Due to Foreign Material

Teva Pharmaceuticals is recalling 175,392 bottles of Trazodone Hydrochloride 50 mg tablets because they may contain foreign tablets or capsules.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The FDA classified this as a Class II recall. Per the rubric, FDA Class II recalls involving significant injury or property damage reports, or structural defects, are rated Severe (4). While specific injury reports are not detailed in the text, the presence of foreign objects in a prescription drug is a significant safety hazard that aligns with the Severe classification for Class II drug recalls.

Plain-English summary

Teva Pharmaceuticals USA, Inc. is recalling 175,392 bottles of Trazodone Hydrochloride Tablets, USP, 50 mg. The recall was initiated because the product may contain foreign tablets or capsules.

The affected product is identified by Lot 1394026 with an expiration date of 02/2028. The tablets were manufactured in Croatia by Pliva Hrvatska d.o.o. and distributed nationwide in the United States.

Consumers should stop using the recalled product and contact their healthcare provider or pharmacist for guidance. The FDA has classified this recall as Class II, indicating a reasonable probability that the use of the product could cause temporary or medically reversible health consequences.

The recalled product

Product
TRAZODONE HYDROCHLORIDE (TRAZODONE HYDROCHLORIDE)
Brand
TRAZODONE HYDROCHLORIDE
Affected units
175,392

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot: 1394026
  • Exp. 02/2028.

UPCs (1)

  • 0350111450011

Distribution

Distributed nationwide across the United States.